The first objective of this study was to determine the baseline prevalence of metabolic syndrome and its individual components using the NCEP-R/ATPIII criteria, IDF criteria for Europe, and IDF criteria for Africa: waist circumference of at least 94 cm for men and women. The second objective was to investigate the incidence and the determinants of type 2 diabetes in a prospective cohort of 807 non-diabetic Central Africans aged ≥ 40 years from December 2004 to September 2008. During 3,156 person-years of median follow up, there were 93 type 2 diabetes cases (11.5%), corresponding to an incidence of 29 (95% CI 15—43) per 1,000 person-years. The independent predictors of incident type 2 diabetes were age ≥ 45 years, physical inactivity, non-diabetic hyperglycaemia and metabolic syndrome regardless of criteria used. In conclusion, urgent prevention strategies are needed to curb the type 2 diabetes epidemic in Africa.
IDF (2006) A consensus statement from the International Diabetes Federation. Diabet Med23: 469-80.
2.
Zimmet P., Alberti Kgmm, Shaw J. ( 2001) Global and societal implications of the diabetes epidemic . Nature414: 782-7.
3.
Fisch A., Pichard E., Prazuck T., Leblanc H., Sidibe Y., Brucker G. ( 1987) Prevalence and risk factors of diabetes mellitus in the rural region of Mali Africa: a practical approach. Diabetologia30: 859-62.
4.
Longo-Mbenza B., Vangu Ngoma D., Nahimana D., et al. (2008) Screen detected and the WHO Stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil15: 503-8.
5.
Otiento CF ( 2007) Type 2 diabetes - an emerging epidemic in Kenya . East Afr Med J84: 249-50.
6.
Lorenzo C., Okoloise M., Williams K., Stern MP, Haffner SM ( 2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care26: 3153-9.
7.
Wilson PW, D’Agostino RB, Parise H., Sullivan L., Meigs JB ( 2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation112: 3066-72.
8.
Wassink AMJ , Van Der Graaf Y., Soedamah-Muthu S., Spiering W., Visseran FLJ ( 2008) Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diabetes Vasc Dis Res5: 114-22.
9.
Chou P., Wu GS ( 1998) Progression to type 2 diabetes among high-risk groups in Kin-Chen Kinen. Diabetes Care21: 1183-7.
10.
Motala AA, Pirie FJ, Gouws E., Amod A., Omar MAK ( 2003) High incidence of type 2 diabetes mellitus in South African Indians: a 10 year for study. Diabetic Med20: 23-30.
11.
Kelliny C., William J., Riesen W., Paccaud F., Bovet P. ( 2008) Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol7: 27, doi:10.1186/1475-2840-7-27.
12.
Kasiam Lasion’kin JB, Longo-Mbenza B., Nge Okwe A., Ditu Mpandamadi S., Okitolonda W., He J. ( 2008) Prevalence and risk factors of diabetes mellitus in Kinshasa Hinterland. Int J Diabetes Metabolism16: 50-9.
13.
Democratic Republic Of Congo (2001) National survey of children and women situation. MICS2 2001. Say yes for children, Vol. 2. Kinshasa: USAID/ WHO/UNICEFV, pp. 40-46.
14.
Ngondo A., Pitshandenge S. ( 1984) Demographic perspectives of Zaïre during 1984-1999 . Cedas1: 31-32.
15.
National Program of Nutrition (2004) Nutrition Survey in Kinshasa Hinterland Region, March 2004. Democratic Republic of Congo, Ministry of Health, pp. 100-106.
16.
WHO (2006) STEPS planning and implementation. The WHO STEPwise approach in the management of non communicable diseases and mental health, WHO/NMH/CCS/03.04. Geneva: WHO.
17.
Longo-Mbenza B., Vangu Ngoma D., Nahimana D., et al. (2008) Screen detected and the WHO Stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil15: 503-508.
18.
http://www.eatlas.org/media
19.
Kish L., Frankel MR ( 1974) Inference from complex samples. J Roy Statist Soc B36: 1-37.
20.
Balde NM, Diallo I., Balde MD, et al. (2007) Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab33: 114-20.
21.
Elbagir MN, Eltom MA, Elmahadi EMA, Kadam IMS, Berne C. ( 1996) A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in Northern Sudan. Diabetes Care19: 1126-8.
22.
WHO (2003) The WHO STEPwise approach to surveillance of non communicable diseases (STEPS) - A framework for surveillance. Geneva: World Health Organization, p. 27.
23.
Lohman TG, Roche AF, Martorell R. ( 1998) Anthropometric Standardization Reference Manual . Champaign, IL: Human Kinetics , pp. 3-8 and 39-70.
24.
Wang J., Thornton JC, Bari S., et al. (2003) Comparison of waist circumferences measured at four sites. Am J Clin Nutr77: 379-84.
25.
WHO (2006) Obesity. Preventing and managing the global epidemic: report of WHO consultation on obesity, 3 - 5 June, 1997. Geneva: WHO.
26.
Joubert J., Norman R., Lambert EV, et al. and the South African Comparative Risk Assessment Collaborating Group (2007) Estimating the burden of disease attributable to physical inactivity in South Africa in 2000. Samj97: 725-31.
27.
World Health Organization ( 2003) The WHO Stepwise approach to surveillance of non communicable diseases (STEPS) - A framework for surveillance. Geneva : WHO.
28.
Price C. ( 2003) Point-of-care testing in diabetes mellitus. Clin Chem Lab Med41: 1213-19.
29.
Faeh D., William J., Tappy L., Ravussin E., Bovet P. ( 2007) Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health7: 163.
30.
Cho HI ( 1999) Twenty-years of experiences in external quality assurance in Korea. Korean Association of Quality Assurance for Clinical Laboratories (KAQACL). Southeast Asian J Trop Med Public Health30 (Suppl 3): 32-8.
31.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care26 (Suppl 1): S5-S20.
32.
Omran AR ( 1971) The epidemiology transition, the key of the epidemiology population change. Milibank Memorial Fund Q49: 509-38.
33.
Moore M., Gould P., Keary BS ( 2003) Global urbanization and impact on health. Int J Hyg Environ Health206: 269-78.
34.
Bonora E., Kiechl S., Willit J. et al. (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals: The Bruneck study. Diabetes53: 1782-9.
35.
Sheu WH, Chuang SY, Lee WJ, Tsai ST, Chou P., Chen CH ( 2006) Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes Res Clin Pract74: 162-8.
36.
Meigs JB, Wilson PW, Fox CS et al. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab91: 2906-12.
37.
Meigs JB, Rutter MK, Sullivan LM, Fox CS, d’Agostino RB Sr , Wilson PW (2007) Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care30: 1219-25.
38.
Wannamethee SG, Shaper AG, Lennon L., Morris RW (2005) Metabolic syndrome vs. Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med165: 2644-50.
39.
Wannamethee SG, Lowe GD, Rumley A., Cherry L., Whincup PH, Sattar N. (2007) Adipokines and risk of type 2 diabetes in older men. Diabetes Care30: 1200-5.
40.
Arcavi L., Behar S., Caspi A., Reshef N., Boyko V., Knobler H. ( 2004) High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study. Am Heart J147: 239-45.
41.
Mbanya JC, Kengne AP, Assah F. ( 2006) Diabetes care in Africa. Lancet368: 1628-9.
42.
Fezeu L., Balkau B., Kengne AP, Sobngwi E., Mbanya JC ( 2006) Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis2006; doi: 10.1016.
43.
Kasiam LasiOn’kin JB, Longo-Mbenza B., Nge Okwe A., Kangola Kabangu N. (2007 ) Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo. Cardiovasc J Afr18: 300-307.
44.
Gupta R., Deedwania PC, Gupta A. et al. (2004) Prevalence of the metabolic syndrome in an Indian urban population. Int J Cardiol97: 257-61.
45.
Gu D., Reynolds K., Wu X. et al. (2005) prevalence of the metabolic syndrome and overweight among adults in China. Lancet365: 1398-405.
46.
International Diabetes Federation (2005) A new worldwide definition of the metabolic syndrome, http://www.idf.org/home (accessed 30 October 2005 ).
47.
Lee JS, Kawakubo K., Mori K., Akabayashi A. ( 2007) Effective cut-off values of waist circumference to detect factors of metabolic syndrome in Japanese men and women. Diabetes Vasc Dis Res4: 340-5.
48.
Enyegue DM, Ngondi JL, Oben JE ( 2008) Comparison and concordance of two metabolic syndrome definitions in Cameroon. Abstracts from the 6th Annual World Congress on the Insulin Resistance Syndrome. 25th-27th September, Hilton, Universal City, Los Angeles, CA, USA, 2008. Diabetes Vasc Dis Res 5: 232 [abstract].
49.
Isezuo SA ( 2005) Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes ? Athn Dis15: 6-10.
50.
Debout F., Haumont S., Gaham N., Amoussou Genou KD, Hermans M. ( 2008) Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA-hyperbolic product. Diabetes Metab Synd Clin Res Rev2: 5-11.
